Sarilumab SAR153191 (REGN88) clinical trials

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

This study is looking at a new medicine called sarilumab for children and teenagers with a type of arthritis called systemic Juvenile Idiopathic Arthritis (sJIA). It aims to find the right dose and see how safe and effective it is.